ABL Bio has ranked among the top searched stocks for 5 days in the past month.

As of 12:31 PM on the 15th, ABL Bio is trading at 29,850 KRW, up 1.36% from the previous day. This represents a 64.01% increase compared to May 27. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.

Today, foreigners have net sold 276,814 shares of ABL Bio, and institutions have net sold 7,000 shares, according to provisional data. Over the past 5 days, individual investors have net bought 455,767 shares, while foreigners and institutions have net bought 303,356 shares and net sold 636,414 shares, respectively.

On June 11, ABL Bio was a market topic for its "strong momentum in advancing the 'bispecific antibody platform technology' transfer."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing